ea0037ep1352 | Endocrine nursing | ECE2015
Rutten Els
, T'Sjoen Guy
, Lapauw Bruno
, Verroken Charlotte
, Feyen Els
Background: Pegvisomant has demonstrated efficacy in attaining IGF1 normalisation in previously uncontrolled acromegalic patients. A home care programme improves treatment compliance.Aims: Evaluation of home educational program and quality of life (Qol).Methods: Multicentre observational study involving eight Flemish centres. Uncontrolled acromegalic out-patients were trained for daily subcutaneous pegvisomant injection at home by ...